Has Tanya Hrabal, MD received payments from drug or device companies?

Yes. Drug and device makers reported $5,764 in general payments to Tanya Hrabal, MD across 70 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Tanya Hrabal, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Tanya Hrabal, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Tanya Hrabal, MD

Family Medicine · Colorado Springs, CONPI 1619912227

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.9% of the total across 70 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,762 and has fallen 91.1% since, to $245 in 2025. Among family medicine clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,764in general payments, 2019–2025

Across 70 payments — averaging $82.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novo Nordisk$1K
AstraZeneca$840
Amgen$800
GSK$500
Sanofi-aventis U.S. LLC$458
Pfizer$283
plus $2K from 15 others

What the payments were for

Food & beverage$5,760100%
Education$40%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novo Nordisk	16	$1,042
AstraZeneca	10	$840
Amgen	9	$800
GSK	5	$500
Sanofi-aventis U.S. LLC	4	$458
Pfizer	6	$283
Biohaven Pharmaceuticals, Inc.	2	$249
Merck	2	$164
Medtronic	2	$161
W. L. Gore & Associates, Inc.	1	$148
Eisai Inc.	2	$128
Esperion Therapeutics, Inc.	1	$125
Janssen Scientific Affairs, LLC	1	$111
Bayer	1	$106
Kowa Pharmaceuticals America, Inc.	1	$105
Therapeuticsmd, Inc.	1	$105
Amarin Pharma, Inc.	1	$94
Boehringer Ingelheim	1	$92
Sunovion Pharmaceuticals Inc.	2	$89
AbbVie	1	$84
Novartis	1	$80

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,764 in reported general payments places this provider in the 95th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado →

Medicare billing

Part B allowed, 2024

$4,039

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Amoxicillin	14	$39

Paid to pharmacies, not to this prescriber.

Other family medicine in Colorado Springs

Matthew YoungColorado Springs$270K
Lawrence AndrewsColorado Springs$102K
Elizabeth EricksonColorado Springs$31K
Daniel RohwederColorado Springs$21K
Gary TarshisColorado Springs$10K
Jeremy BrownColorado Springs$8K
Ethan LazarusDenver$688K
Michael de NardisLarkspur$335K
Mark DeutchmanDenver$258K
Kari UusinarkausWoodland Park$254K

See the full list for Colorado →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →